Progressive Care Inc. Doubles
Revenue: Reports $3.3 Million for June 2019
MIAMI,
FL -- July 17, 2019 -- InvestorsHub NewsWire
-- Progressive
Care Inc. (OTCQB:
RXMD),
a personalized healthcare services and technology company, today
announced record
revenues of $3.3 Million for June 2019 and an 80% increase in
prescriptions filled at nearly 46,000 total.
June
2019 represents the first month of consolidated revenue for
Progressive Care,
which
includes 4 locations in Florida. The Company recorded
a
100% increase in gross revenues at $3.3 million exclusive
of PBM fees and nearly 46,000 prescriptions filled. Prescriptions
filled have grown steadily for all locations, especially PharmCo
Palm Beach which increased by 38% and yielded a 165% increase in
revenues.
"This was the first month
of having
4 locations under our umbrella," said S. Parikh Mars, Chief
Executive Officer of Progressive Care Inc. "We are more than pleased with
the performance last month as it exceeded our expectations. Yet, we
are focused on the potential for growth and are working on major
big picture goals throughout the rest of the
year."
For
more information about Progressive Care, please visit the
company's website.
Connect and stay
in touch with us on social media:
Progressive
Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo,
LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About
Progressive Care Inc.
Progressive Care
Inc. (OTCQB: RXMD), through its
PharmCo and Five Star
pharmacies, is a South Florida health
services organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements
contained herein that are not based upon current or historical fact
are forward-looking in nature and constitute forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934.
Such forward-looking statements reflect the Company's expectations
about its future operating results, performance, and opportunities
that involve substantial risks and uncertainties. These statements
include but are not limited to statements regarding the intended
terms of the offering, closing of the offering and use of any
proceeds from the offering. When used herein, the words
"anticipate," "believe," "estimate," "upcoming," "plan," "target,"
"intend" and "expect" and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Investor
Relations Contact:
Armen Karapetyan,
Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public
Relations Contact:
Kathleen
Gonzales, CMW Media
Kathleen@cmwmedia.com
www.cmwmedia.com
Web and
Application Development Contact:
Marcello Jaspan,
Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com